Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diabetes Mellitus as a Risk Factor for Parkinson’s Disease: a Molecular Point of View
Alice Biosa, Tiago F. Outeiro, Luigi Bubacco, et al.
Molecular Neurobiology (2018) Vol. 55, Iss. 11, pp. 8754-8763
Closed Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Methylglyoxal, a Highly Reactive Dicarbonyl Compound, in Diabetes, Its Vascular Complications, and Other Age-Related Diseases
Casper G. Schalkwijk, Coen D.A. Stehouwer
Physiological Reviews (2019) Vol. 100, Iss. 1, pp. 407-461
Open Access | Times Cited: 441
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Anna Masato, Nicoletta Plotegher, Daniela Boassa, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 270
The Association Between Type 2 Diabetes Mellitus and Parkinson’s Disease
Julia L.Y. Cheong, Eduardo De Pablo‐Fernández, Thomas Foltynie, et al.
Journal of Parkinson s Disease (2020) Vol. 10, Iss. 3, pp. 775-789
Open Access | Times Cited: 179
Glucose, glycolysis, and neurodegenerative diseases
Bor Luen Tang
Journal of Cellular Physiology (2020) Vol. 235, Iss. 11, pp. 7653-7662
Closed Access | Times Cited: 156
Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment
Katherine O. Kopp, Elliot J. Glotfelty, Yazhou Li, et al.
Pharmacological Research (2022) Vol. 186, pp. 106550-106550
Open Access | Times Cited: 123
Dietary polyphenols: regulate the advanced glycation end products-RAGE axis and the microbiota-gut-brain axis to prevent neurodegenerative diseases
Yueqin Li, Yao Peng, Yingbin Shen, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 29, pp. 9816-9842
Closed Access | Times Cited: 103
Impairment of insulin signaling pathway PI3K/Akt/mTOR and insulin resistance induced AGEs on diabetes mellitus and neurodegenerative diseases: a perspective review
Kanagavalli Ramasubbu, V. Devi Rajeswari
Molecular and Cellular Biochemistry (2022) Vol. 478, Iss. 6, pp. 1307-1324
Closed Access | Times Cited: 89
The Relevance of Insulin Action in the Dopaminergic System
Francesca Fiory, Giuseppe Perruolo, Ilaria Cimmino, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 93
Peripheral inflammation exacerbates α‐synuclein toxicity and neuropathology in Parkinson's models
Pietro La Vitola, Claudia Balducci, Michela Baroni, et al.
Neuropathology and Applied Neurobiology (2020) Vol. 47, Iss. 1, pp. 43-60
Closed Access | Times Cited: 73
Metformin Repurposing for Parkinson Disease Therapy: Opportunities and Challenges
Francesco Agostini, Anna Masato, Luigi Bubacco, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 398-398
Open Access | Times Cited: 63
Parkinson’s disease and diabetes mellitus: common mechanisms and treatment repurposing
CarmenM Labandeira, Arturo Fraga-Bau, David Arias Ron, et al.
Neural Regeneration Research (2021) Vol. 17, Iss. 8, pp. 1652-1652
Open Access | Times Cited: 62
Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson’s disease mouse model
Yiqing Lv, Lin Yuan, Yan Sun, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 55
NF‐κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 13, pp. 1775-1789
Open Access | Times Cited: 33
Semaglutide Attenuates Anxious and Depressive-Like Behaviors and Reverses the Cognitive Impairment in a Type 2 Diabetes Mellitus Mouse Model Via the Microbiota-Gut-Brain Axis
Igor Henrique Rodrigues de Paiva, Rodrigo Soares da Silva, Ingrid Prata Mendonça, et al.
Journal of Neuroimmune Pharmacology (2024) Vol. 19, Iss. 1
Closed Access | Times Cited: 10
A Network-Based Bioinformatics Approach to Identify Molecular Biomarkers for Type 2 Diabetes that Are Linked to the Progression of Neurological Diseases
Md Habibur Rahman, Silong Peng, Xiyuan Hu, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 3, pp. 1035-1035
Open Access | Times Cited: 65
Diabetes Mellitus and Parkinson's Disease: Shared Pathophysiological Links and Possible Therapeutic Implications
Abdallah Hassan, Rajan Sharma Kandel, Rohi Mishra, et al.
Cureus (2020)
Open Access | Times Cited: 63
Thioredoxin-Interacting Protein (TXNIP) Regulates Parkin/PINK1-mediated Mitophagy in Dopaminergic Neurons Under High-glucose Conditions: Implications for Molecular Links Between Parkinson’s Disease and Diabetes
Cunjin Su, Zhu Shen, Ru-Xiao Cui, et al.
Neuroscience Bulletin (2020) Vol. 36, Iss. 4, pp. 346-358
Open Access | Times Cited: 50
Unraveling Parkinson’s Disease Neurodegeneration: Does Aging Hold the Clues?
Colin Coleman, Ian Martin
Journal of Parkinson s Disease (2022) Vol. 12, Iss. 8, pp. 2321-2338
Open Access | Times Cited: 34
Antidiabetic drugs for Alzheimer's and Parkinson's diseases: Repurposing insulin, metformin, and thiazolidinediones
Susana Cardoso, Paula I. Moreira
International review of neurobiology (2020), pp. 37-64
Closed Access | Times Cited: 45
Synergistic Effects of Milk-Derived Exosomes and Galactose on α-Synuclein Pathology in Parkinson’s Disease and Type 2 Diabetes Mellitus
Bodo C. Melnik
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1059-1059
Open Access | Times Cited: 37
Diabetes and Parkinson’s Disease: Understanding Shared Molecular Mechanisms
Annekatrin König, Tiago F. Outeiro
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 5, pp. 917-924
Open Access | Times Cited: 5
Diabetes mellitus and Parkinson’s disease: dangerous liaisons between insulin and dopamine
Carlo Colosimo, Angela De Iuliis, Ennio Montinaro, et al.
Neural Regeneration Research (2021) Vol. 17, Iss. 3, pp. 523-523
Open Access | Times Cited: 30
The epigenetic mechanisms involved in mitochondrial dysfunction: Implication for Parkinson’s disease
Zixuan Chen, Madiha Rasheed, Yulin Deng
Brain Pathology (2021) Vol. 32, Iss. 3
Open Access | Times Cited: 29
Methylglyoxal in the Brain: From Glycolytic Metabolite to Signalling Molecule
Zeyong Yang, Wangping Zhang, Lu Han, et al.
Molecules (2022) Vol. 27, Iss. 22, pp. 7905-7905
Open Access | Times Cited: 17
Neuroprotective effects of semaglutide and metformin against rotenone-induced neurobehavioral changes in male diabetic rats
Esraa A. Salem, Saad Misfer Alqahtani, Ehab A. M. El‐Shoura, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
Page 1 - Next Page

Scroll to top